Capricor Therapeutics (CAPR)
(Delayed Data from NSDQ)
$6.15 USD
+0.06 (0.99%)
Updated Sep 23, 2025 04:00 PM ET
After-Market: $6.15 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Capricor Therapeutics, Inc. has a market cap of $278.42M, which represents its share price of $6.09 multiplied by its outstanding shares number of 45.72M. As a small-cap company, CAPR's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CAPR 6.15 +0.06(0.99%)
Will CAPR be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CAPR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CAPR
Quanterix Corporation (QTRX) Reports Q2 Loss, Misses Revenue Estimates
FDA Rejects CAPR's Cell Therapy BLA for Genetic Disorder, Stock Tanks
CAPR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Capricor (CAPR) Moves 20.4% Higher: Will This Strength Last?
Capricor Therapeutics (CAPR) Reports Q4 Loss, Tops Revenue Estimates
QuidelOrtho (QDEL) Q4 Earnings and Revenues Top Estimates
Other News for CAPR
Is CAPR ready to move lower? Fell Below 20 Day Moving Average shows up after plummeting 8.42%
20 Day Moving Average Support appears for CAPR after 3.91% move
CAPR Crossed Above 20 Day Moving Average on September 19
CAPR forms Bollinger Band Squeeze on September 17
Is CAPR building pressure? Bollinger Band Squeeze shows up after rising 2.98%